• Tangible book value per share of Viridian Therapeutics, Inc. – HAM:1S1 TradingView Thu, 09 Jul 2026 18:54:35 GMT
• viridian therapeutics outlines eye disease strategy as nasdaq-listed biotech builds its pipeline Ad-hoc-news.de Wed, 08 Jul 2026 15:57:40 GMT
• Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone Yahoo Finance Mon, 06 Jul 2026 17:21:41 GMT
• The Bull Case For Viridian Therapeutics (VRDN) Could Change Following FDA Approval Of Lumvoa For Thyroid Eye Disease simplywall.st Mon, 06 Jul 2026 11:28:11 GMT
• If You Invested $1,000 in Viridian Therapeutics Inc (VRDN) Stock Titan Sat, 04 Jul 2026 08:28:47 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Fri, 03 Jul 2026 18:09:59 GMT
• Director Ajer granted 32,341 Viridian Therapeutics (VRDN) stock options at $18.48 Stock Titan Thu, 02 Jul 2026 20:17:15 GMT
• Viridian Therapeutics (VRDN) director receives 32,341 stock options at $18.48 strike Stock Titan Thu, 02 Jul 2026 20:17:15 GMT
• Viridian Therapeutics (VRDN) director-linked funds receive 32,341 options Stock Titan Thu, 02 Jul 2026 20:17:14 GMT
• Fairmount-linked entities receive 32,341 Viridian (VRDN) stock options at $18.48 Stock Titan Thu, 02 Jul 2026 20:15:37 GMT
• a quick look at today's ratings for viridian therapeutics(vrdn.us), with a forecast between $22 to $35 富途牛牛 Thu, 02 Jul 2026 11:11:04 GMT
• vrdn stock jumps 6% after-hours as viridian wins first fda approval Stocktwits Thu, 02 Jul 2026 03:34:20 GMT
• VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know TradingView Wed, 01 Jul 2026 14:41:00 GMT
• rx rundown: zymeworks, viridian therapeutics, biocryst and more Medical Marketing and Media Wed, 01 Jul 2026 12:04:23 GMT
• Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - S... Seeking Alpha Wed, 01 Jul 2026 10:21:28 GMT
• Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $40 Moomoo Wed, 01 Jul 2026 03:32:00 GMT
• Jefferies Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $30 Moomoo Tue, 30 Jun 2026 23:03:12 GMT
• Viridian Therapeutics (VRDN) Wins FDA Approval For Lumvoa, Is The Upside Already Priced In? simplywall.st Tue, 30 Jun 2026 22:23:29 GMT
• vrdn maintained by needham -- price target raised to $34.00 GuruFocus Tue, 30 Jun 2026 19:10:31 GMT
• RBC Lifts Price Target on Viridian Therapeutics to $35 From $34, Keeps Outperform, Speculative Risk Moomoo Tue, 30 Jun 2026 18:36:09 GMT
• vrdn maintained by rbc capital -- price target raised to $35.00 GuruFocus Tue, 30 Jun 2026 16:25:25 GMT
• viridian therapeutics' lumvoa could start generating more meaningful revenue in 2027, rbc says marketscreener.com Tue, 30 Jun 2026 15:54:34 GMT
• vrdn maintained by wedbush -- price target raised to $43.00 GuruFocus Tue, 30 Jun 2026 15:23:09 GMT
• A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $43 Moomoo Tue, 30 Jun 2026 13:00:00 GMT
• viridian therapeutics: lumvoa ready for prime-time following fda approval (nasdaq:vrdn) Seeking Alpha Tue, 30 Jun 2026 12:30:04 GMT
• Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval (NASDAQ:VRDN) Seeking Alpha Tue, 30 Jun 2026 12:30:00 GMT
• analysts offer insights on healthcare companies: viridian therapeutics (vrdn) and cytokinetics (cytk) The Globe and Mail Tue, 30 Jun 2026 10:24:00 GMT
• Viridian may have edge over Amgen in eye drug showdown, analysts argue BioPharma Dive Tue, 30 Jun 2026 07:00:00 GMT
• Viridian Therapeutics Receives FDA Approval for Lumvoa for the Treatment of Thyroid Eye Disease (TED) VisionMonday.com Tue, 30 Jun 2026 04:21:00 GMT
• viridian launches first commercial product as us approves thyroid eye disease therapy MSN Mon, 29 Jun 2026 23:06:46 GMT
• exclusive bac article: viridian therapeutics; fda approval lumvoa [veligrotug] ted, ema review underway, bla submission sc version... Seeking Alpha Mon, 29 Jun 2026 19:47:21 GMT
• vrdn upgraded by wells fargo -- price target raised to $31 GuruFocus Mon, 29 Jun 2026 19:23:06 GMT
• executives at viridian therapeutics disclosed during a conference call that the pricing plan for a five-infusion course of its dru... Bitget Mon, 29 Jun 2026 18:49:44 GMT
• Wedbush raises Viridian Therapeutic stock price target to $43 Investing.com Mon, 29 Jun 2026 17:28:57 GMT
• (vrdn) price dynamics and execution-aware positioning Stock Traders Daily Mon, 29 Jun 2026 17:04:01 GMT
• truist reiterates buy on viridian stock after fda approval by investing.com Investing.com Australia Mon, 29 Jun 2026 16:37:43 GMT
• New Viridian meridian? Hopes veli high in TED post-FDA win BioWorld News Mon, 29 Jun 2026 16:00:00 GMT
• viridian therapeutics (vrdn) receives upgrade from wells fargo GuruFocus Mon, 29 Jun 2026 14:33:59 GMT
• Wells Fargo Upgrades Viridian Therapeutics(VRDN.US) to Buy Rating, Raises Target Price to $31 Moomoo Mon, 29 Jun 2026 14:12:30 GMT
• Wells Fargo Upgrades Viridian Therapeutics to Overweight From Equalweight Moomoo Mon, 29 Jun 2026 14:00:32 GMT
• viridian secures first fda approval, sets up challenge to amgen's tepezza for thyroid eye disease Benzinga Mon, 29 Jun 2026 13:24:47 GMT
• dri healthcare comments on viridian’s fda approval and launch of lumvoa™ (veligrotug-vvze) Cantech Letter Mon, 29 Jun 2026 12:14:24 GMT
• vrdn reiterated by needham -- price target maintained at $32 GuruFocus Mon, 29 Jun 2026 12:11:03 GMT
• Viridian Therapeutic stock gets FDA approval for thyroid eye disease drug Investing.com Nigeria Mon, 29 Jun 2026 12:07:57 GMT
• viridian debuts on market with fda greenlight for thyroid eye disease drug BioSpace Mon, 29 Jun 2026 12:01:09 GMT
• comcast, viridian therapeutics jump premarket; doximity slips Investing.com Mon, 29 Jun 2026 11:41:02 GMT
• FDA clears Viridian's Tepezza rival for thyroid eye disease pharmaphorum Mon, 29 Jun 2026 11:12:49 GMT
• dri healthcare comments on viridian's fda approval and launch of lumvoa™ (veligrotug-vvze) Yahoo Finance Mon, 29 Jun 2026 11:00:00 GMT
• viridian wins fda approval for lumvoa for thyroid eye disease PharmaTimes Mon, 29 Jun 2026 10:39:33 GMT
• Viridian Therapeutics (VRDN) Soars 12% Following FDA Approval of Lumvoa GuruFocus Mon, 29 Jun 2026 10:17:10 GMT
• analysts are bullish on these healthcare stocks: viridian therapeutics (vrdn), genfleet therapeutics (shanghai), inc. class h (hk:... The Globe and Mail Mon, 29 Jun 2026 09:04:45 GMT
• Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa Fierce Pharma Mon, 29 Jun 2026 07:00:00 GMT
• UBS reiterates Viridian Therapeutic stock rating on FDA approval Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• Viridian Therapeutic stock rating reiterated at Outperform by William Blair Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• fda approves viridian’s eye drug, stoking competition with amgen’s tepezza Endpoints News Mon, 29 Jun 2026 07:00:00 GMT
• concentrix, aerovironment and 3 stocks to watch heading into monday Benzinga Mon, 29 Jun 2026 06:34:17 GMT
• Why Viridian Therapeutics (VRDN) Is Up 7.6% After FDA Clears First All‑Stage Thyroid Eye Drug simplywall.st Mon, 29 Jun 2026 03:53:59 GMT
• weekly update: revisiting viridian therapeutics after fda approval of lumvoa for the treatment of thyroid eye disease (ted) (nasda... Seeking Alpha Sun, 28 Jun 2026 21:04:26 GMT
• fda approves viridian’s thyroid eye disease drug, competitor to a blockbuster amgen med MedCity News Sun, 28 Jun 2026 21:03:09 GMT
• viridian's thyroid eye disease drug wins fda nod, squaring off with amgen's tepezza FirstWord Pharma Sun, 28 Jun 2026 17:56:02 GMT
• Price to earnings forward of Viridian Therapeutics, Inc. – NASDAQ:VRDN TradingView Sun, 28 Jun 2026 12:17:52 GMT
• Why Viridian Therapeutics (VRDN) Is Up 7.6% After FDA Clears First All‑Stage Thyroid Eye Drug Sahm Sun, 28 Jun 2026 07:00:00 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Sun, 28 Jun 2026 06:07:25 GMT
• vrdn stock jumps 6% after-hours as viridian wins first fda approval Stocktwits Sun, 28 Jun 2026 04:44:54 GMT
• viridian therapeutics (vrdn) launches lumvoa following fda appro GuruFocus Sun, 28 Jun 2026 03:40:48 GMT
• viridian therapeutics’ stock up 35% after phase iii ted data release MSN Sun, 28 Jun 2026 00:15:52 GMT
• enterprise value to ebit forward of viridian therapeutics, inc. – nasdaq:vrdn TradingView Sat, 27 Jun 2026 23:55:30 GMT
• fda approves veligrotug-vvze (lumvoa) for thyroid eye disease across active and chronic stages Ophthalmology Times Sat, 27 Jun 2026 19:24:28 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Sat, 27 Jun 2026 18:06:26 GMT
• price to sales forward of viridian therapeutics, inc. – nasdaq:vrdn TradingView Sat, 27 Jun 2026 17:10:03 GMT
• enterprise value to revenue forward of viridian therapeutics, inc. – nasdaq:vrdn TradingView Sat, 27 Jun 2026 16:39:36 GMT
• viridian therapeutics (vrdn) launches lumvoa following fda appro GuruFocus Sat, 27 Jun 2026 16:07:14 GMT
• viridian launches first commercial product as u.s. approves thyroid eye disease therapy Seeking Alpha Sat, 27 Jun 2026 15:37:30 GMT
• viridian therapeutics wins fda nod for lumvoa for ted The Pharma Letter Sat, 27 Jun 2026 14:30:51 GMT
• enterprise value to ebitda forward of viridian therapeutics, inc. – nasdaq:vrdn TradingView Sat, 27 Jun 2026 11:00:14 GMT
• price to book forward of viridian therapeutics, inc. – gettex:1s1 TradingView Sat, 27 Jun 2026 08:51:07 GMT
• Viridian thyroid eye disease drug approved (VRDN:NASDAQ) Seeking Alpha Sat, 27 Jun 2026 07:00:00 GMT
• us fda greenlights viridian’s thyroid eye disease drug The Mighty 790 KFGO Sat, 27 Jun 2026 04:02:06 GMT
• fda approves viridian's lumvoa for thyroid eye disease (ted) Eyewire+ Fri, 26 Jun 2026 23:24:14 GMT
• Viridian Therapeutics (VRDN) Receives FDA Approval for Lumvoa Tr GuruFocus Fri, 26 Jun 2026 22:52:09 GMT
• fda approves viridian’s eye drug, stoking competition with amgen’s tepezza Endpoints News Fri, 26 Jun 2026 22:52:00 GMT
• fda approves viridian eye drug, stoking competition with amgen’s tepezza Endpoints News Fri, 26 Jun 2026 22:52:00 GMT
• Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease... Business Wire Fri, 26 Jun 2026 07:00:00 GMT
• FDA approves Lumvoa for thyroid eye disease as Viridian (VRDN) readies launch Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Paradigm entities report combined stake in Viridian Therapeutics (NASDAQ: VRDN) Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval Yahoo Finance Fri, 26 Jun 2026 07:00:00 GMT
• viridian therapeutics, inc. actuals & estimates (nasdaq:vrdn) TradingView Fri, 26 Jun 2026 05:12:07 GMT
• retinitis pigmentosa market unlocking new revenue opportunities and strategic expansion by 2034 – delveinsight | sparingvision sas... Barchart.com Thu, 25 Jun 2026 12:30:18 GMT
• Viridian Therapeutics: A Two-Step TED Franchise With More Leverage Than The Market Appreciates Seeking Alpha Thu, 25 Jun 2026 07:00:00 GMT
• viridian therapeutics inc (vrdn) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• viridian therapeutics inc (vrdn) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• viridian therapeutics’ stock up 35% after phase iii ted data release MSN Sun, 21 Jun 2026 19:39:28 GMT
• should surging big‑ticket ownership amid ongoing losses require action from viridian therapeutics (vrdn) investors? simplywall.st Sun, 21 Jun 2026 00:37:49 GMT
• viridian therapeutics (vrdn) stock could be 84.84% below fair value after institutional buying simplywall.st Fri, 19 Jun 2026 07:00:00 GMT
• (vrdn) as a liquidity pulse for institutional tactics Stock Traders Daily Thu, 18 Jun 2026 15:52:01 GMT
• viridian therapeutics: advancing toward commercialization leadership in thyroid eye disease Kalkine Thu, 18 Jun 2026 13:43:16 GMT
• viridian therapeutics inc (vrdn) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 09:16:37 GMT
• viridian therapeutics inc (vrdn) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 08:53:52 GMT
• viridian therapeutics inc (vrdn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 08:29:45 GMT
• viridian therapeutics inc (vrdn) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 06:07:51 GMT
• viridian therapeutics inc (vrdn) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:31:44 GMT
• viridian therapeutics inc (vrdn) institutional confidence TradingKey Thu, 18 Jun 2026 05:31:42 GMT
• viridian therapeutics inc (vrdn) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 05:29:38 GMT
• viridian therapeutics inc (vrdn) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:23:32 GMT
• viridian therapeutics inc (vrdn) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 05:17:48 GMT
• wells fargo maintains viridian therapeutics(vrdn.us) with hold rating, maintains target price $20 富途牛牛 Wed, 17 Jun 2026 11:31:00 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Wed, 17 Jun 2026 03:13:45 GMT
• viridian therapeutics’ stock up 35% after phase iii ted data release MSN Wed, 17 Jun 2026 01:34:41 GMT
• viridian therapeutics inc. (vrdn) q1 2026 earnings: narrower-than-expected loss drives modest stock uptick - tangible book value newsline.com Sat, 13 Jun 2026 18:48:18 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Fri, 12 Jun 2026 12:32:38 GMT
• analysts offer insights on healthcare companies: cullinan management (cgem) and viridian therapeutics (vrdn) The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
• goldman sachs maintains viridian therapeutics(vrdn.us) with buy rating, raises target price to $35 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• viridian therapeutics (vrdn) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Tue, 09 Jun 2026 07:00:00 GMT
• vrdn: approval expected june 30, with launch-ready teams and strong clinical differentiation TradingView Tue, 09 Jun 2026 07:00:00 GMT
• does viridian therapeutics (vrdn) early debt repayment reveal a new capital discipline strategy? simplywall.st Sun, 07 Jun 2026 15:31:08 GMT
• rbc capital raises viridian therapeutic stock price target to $34 on trial data Investing.com Sat, 06 Jun 2026 05:42:21 GMT
• vrdn stock falls to 9-month lows – what’s the amgen connection? Stocktwits Fri, 05 Jun 2026 15:56:36 GMT
• rbc capital raises viridian therapeutic stock price target to $34 on trial data Investing.com Thu, 04 Jun 2026 20:47:27 GMT
• amgen follows viridian's massive dive with positive eye drug results Investor's Business Daily Thu, 04 Jun 2026 13:00:00 GMT
• viridian therapeutics stock tumbles after amgen tepezza data by investing.com Investing.com Nigeria Thu, 04 Jun 2026 07:00:00 GMT
• viridian therapeutics shareholders approve directors and governance items TipRanks Wed, 03 Jun 2026 14:09:57 GMT
• viridian therapeutics (vrdn) jefferies global healthcare conference 2026 summary Quartr Wed, 03 Jun 2026 07:00:00 GMT
• vrdn: ready for ted drug launch in 2026, aiming for broad access and major market expansion TradingView Wed, 03 Jun 2026 07:00:00 GMT
• [8-k] viridian therapeutics, inc.\de reports material event | vrdn 8-k filing Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Viridian ties up WuXi supply deal ahead of TED decision The Pharma Letter Mon, 01 Jun 2026 07:00:00 GMT
• how investors may respond to viridian therapeutics (vrdn) debt repayment and wuxi manufacturing pact simplywall.st Sat, 30 May 2026 17:17:31 GMT
• vrdn q1 2026 earnings: eps surpasses estimates by 19.37% as clinical pipeline advances - estimate uncertainty The Legal Advocate Sat, 30 May 2026 10:37:42 GMT
• viridian therapeutics (vrdn) edges higher amid modest trading activity - insider buying alerts newsline.com Fri, 29 May 2026 07:00:00 GMT
• hot picks: biotech stocks gain momentum on m&a activity BNN Bloomberg Thu, 28 May 2026 18:31:20 GMT
• viridian therapeutics (nasdaq: vrdn) retires $55.1m hercules term loan years early Stock Titan Thu, 28 May 2026 07:00:00 GMT
• viridian therapeutics, inc. announces voluntary prepayment and termination of loan agreement marketscreener.com Thu, 28 May 2026 07:00:00 GMT
• viridian therapeutics to present at goldman sachs and jefferies healthcare conferences in june geneonline.com Thu, 28 May 2026 00:22:37 GMT
• (vrdn) movement as an input in quant signal sets Stock Traders Daily Wed, 27 May 2026 13:14:02 GMT
• Viridian, awaiting FDA decision, taps WuXi Bio in supply deal Fierce Pharma Wed, 27 May 2026 07:00:00 GMT
• viridian therapeutics to participate in upcoming june investor conferences Business Wire Wed, 27 May 2026 07:00:00 GMT
• viridian therapeutics secures wuxi deal for veligrotug manufacturing The Globe and Mail Wed, 27 May 2026 07:00:00 GMT
• viridian therapeutics signs manufacturing deal with wuxi biologics for thyroid eye disease drug ETPharma.com Wed, 27 May 2026 07:00:00 GMT
• viridian therapeutics to present at goldman sachs and jefferies healthcare conferences in june geneonline.com Wed, 27 May 2026 07:00:00 GMT
Viridian Therapeutics, Inc.(NASDAQ:VRDN) 
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibod...
Share this website to your friends